Biliary Diarrhea Management

Introduction to Biliary Diarrhea

Biliary diarrhea occurs when excessive bile acids enter the colon, stimulating electrolyte and water secretion, resulting in loose to watery stools, with common causes including post-cholecystectomy syndrome, bile acid malabsorption, ileal disease or resection, idiopathic bile acid malabsorption, and biliary obstruction with altered bile flow 1

The American College of Radiology recommends primary treatment of mechanical restoration of biliary drainage for biliary obstruction, with appropriate antibiotics for cholangitis, such as third-generation cephalosporins, ureidopenicillins, carbapenems, or fluoroquinolones 1
Endoscopic retrograde cholangiopancreatography (ERCP) is the treatment of choice for biliary decompression in patients with moderate/severe acute cholangitis, according to the World Journal of Emergency Surgery 2
Percutaneous biliary drainage should be reserved for patients in whom ERCP fails, as stated by the World Journal of Emergency Surgery 2
Bile acid sequestrants, such as cholestyramine, colestipol, or colesevelam, are the first-line treatment for diarrhea after gallbladder removal, with loperamide recommended as an effective alternative or adjunctive therapy, according to the American Gastroenterological Association 3
Anti-motility agents such as loperamide (4-16 mg per day) and codeine sulfate (15-60 mg two to three times daily) can be considered for the treatment of bile acid diarrhea 4, 5
Octreotide may be considered for the treatment of bile acid diarrhea, with a dose of 100-150 μg subcutaneous or IV three times daily 4, 6
Obeticholic acid may be considered in refractory cases of bile acid diarrhea, based on emerging evidence, although the strength of evidence for this recommendation is not specified 4

The starting dose of cholestyramine is 2-4 g/day, with a maximum dose of 24 g/day, and should be taken with meals, as recommended by the American College of Gastroenterology 3
The initial dose of loperamide is 4 mg followed by 2 mg after each unformed stool, with a maximum dose of 16 mg/day, and is effective for diarrhea in irritable bowel syndrome (IBS) and may be used for post-cholecystectomy diarrhea, as stated by the National Institute of Diabetes and Digestive and Kidney Diseases 7, 8
Colestipol is recommended as a second-line bile acid sequestrant after cholestyramine, with a starting dose of 1 g twice daily, and a maximum dose of up to 16 g daily (tablelets) or 30 g daily (granules) 4
Colesevelam can be given at 625 mg tablets, 3 tablets twice daily, for a total of 3.75 g/day, and is better tolerated than cholestyramine but may be less effective 4

Reducing fat consumption can help limit steatorrhea in patients with bile acid diarrhea 4
Avoiding spices, coffee, and alcohol, and considering lactose restriction if intolerance is suspected, may also be beneficial in managing bile acid diarrhea 4, 6, 9
Ensuring adequate fluid intake, at least 1.5 L/day, and separating liquids from solids during meals may also help manage symptoms 4, 9

Patients should be monitored for nutritional deficiencies (especially fat-soluble vitamins A, D, E, K) and long-term therapy should use the lowest effective dose, according to the European Society of Gastrointestinal Endoscopy 3
Response to therapy should be assessed within 2-4 weeks, and consideration should be given to intermittent, on-demand dosing once symptoms are controlled 4
Monitoring for nutritional deficiencies, especially fat-soluble vitamins (A, D, E, K), is recommended, as well as reviewing concurrent medications that may contribute to diarrhea 4

Contraindications for colestipol include patients with Crohn's disease with extensive ileal involvement or resection (>100 cm) as it may worsen steatorrhea, as stated by the American Gastroenterological Association 4
Long-term use of colestipol may affect absorption of fat-soluble vitamins (A, D, E, K), as reported by the National Institutes of Health 4
Bile acid sequestrants should be avoided in patients with extensive ileal disease or resection (Type I), as they may worsen steatorrhea 4
Colestipol can bind with and reduce absorption of many medications, including thyroid preparations, warfarin, diuretics, digoxin, and antibiotics, according to the American College of Gastroenterology 4

Consider bile acid malabsorption (BAM) if diarrhea persists despite optimizing lactulose dosing, and a SeHCAT scan can confirm diagnosis where available 10
Small intestinal bacterial overgrowth (SIBO) should be ruled out, as it is common after gallbladder removal, and consider empiric treatment with rifaximin or other broad-spectrum antibiotics 11
Evaluation for other post-cholecystectomy complications, such as biliary stricture, retained common bile duct stones, and functional bowel disorders, is necessary 11